Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Rev. bras. farmacogn ; 24(6): 683-690, Nov-Dec/2014. tab, graf
Article in English | LILACS | ID: lil-741845

ABSTRACT

The roots from Operculina macrocarpa (L.) Urb., Convolvulaceae, are widely used in Brazilian traditional medicine as a laxative and purgative. The biological properties of this drug material have been attributed to its polysaccharides content. Thus, the aim of this study was to evaluate the polysaccharide content in drug material from O. macrocarpa by spectrophotometric quantitative analysis. The root was used as plant material and the botanical identification was performed by macro and microscopic analysis. The plant material was used to validate the spectrophotometric procedures at 490 nm for the quantification of the reaction product from drug polysaccharides and phenol-sulfuric acid solution. The analytical procedure was evaluated in order to comply with the necessary legal requirements by the determination of the following parameters: specificity, linearity, selectivity, precision, accuracy and robustness. This study provides with a simple and valid analytical procedure (linear, precise, accurate and reproducible), which can be satisfactorily used for quality control and standardization of herbal drug from O. macrocarpa.

2.
Braz. j. pharm. sci ; 48(3): 469-476, July-Sept. 2012. graf, tab
Article in English | LILACS | ID: lil-653461

ABSTRACT

The tincture of Operculina alata, popularly known as "tincture of jalapa", is used in Northeast Brazil to treat constipation and encephalic vascular accident, but it has not yet been adequately tested for safety and efficacy. The aim of this study was to evaluate the toxicology and safety of the tincture of O. alata in patients with functional constipation. This was a double-blind, randomized, placebo-controlled clinical trial. The study consisted of three phases: pre-treatment, treatment and post-treatment, each phase with duration of seven days. Arterial pressure, heart rate, body weight, adverse events, hematological, metabolic, liver and kidney functions were monitored. Forty patients were randomized to receive tincture of O. alata and 43 patients to receive placebo. There were statistical differences in the clinical aspects between groups, but these changes were not considered clinically significant. Adverse events were considered not serious and of mild intensity, especially dizziness, headache, abdominal pain and nausea. This clinical trial confirmed the safety of the tincture of O. alata in the pharmaceutical form and dosage tested, allowing the product to be safely used in a larger population for the assessment of its clinical efficacy.


A tintura de Operculina alata, popularmente conhecida como "tintura de jalapa", é usada no Nordeste do Brasil para tratar constipação intestinal e acidente vascular encefálico, mas sua eficácia e segurança ainda não foram confirmadas. O objetivo deste estudo foi avaliar a toxicologia e segurança da tintura de O. alata em pacientes com constipação intestinal funcional. Este foi um ensaio clínico duplo-cego, randomizado e controlado por placebo. O estudo consistiu de três fases: pré-tratamento, tratamento e pós-tratamento, cada fase com duração de sete dias. Foram monitorizados a pressão arterial, frequência cardíaca, peso corporal, eventos adversos e funções hematológica, metabólica, hepática e renal. Quarenta pacientes foram randomizados para receber tintura de O. alata e 43 pacientes para receber placebo. Houve diferenças estatísticas nos aspectos clínicos entre os grupos, contudo, estas mudanças não foram consideradas clinicamente significativas. Eventos adversos foram considerados não sérios e de leve intensidade, especialmente, cefaléia, tontura, dor abdominal e náusea. Este ensaio clínico confirmou a segurança da tintura de O. alata na forma farmacêutica e dosagem testada, permitindo que o produto seja testado em população maior para determinar sua eficácia clínica.


Subject(s)
Humans , Safety , Toxicology/methods , Convolvulaceae/physiology , Clinical Trial
3.
Indian J Biochem Biophys ; 2010 June; 47(3): 157-160
Article in English | IMSEAR | ID: sea-135260

ABSTRACT

Biosynthesis of gold nanoparticles has emerged as an important area in nanotechnology and biotechnology due to growing need to develop environmentally benign technologies. Generally, nanoparticles are prepared by a variety of chemical methods which are not environmentally friendly. In the present study, we report a rapid and convenient method to reductively prepare gold nanoparticles from auric chloride using aqueous extract of Mirabilis jalapa flowers. The flower extract acts as a reducing agent and encapsulating cage for the gold nanoparticles. The production of gold nanoparticles has been done by the controlled reduction of the Au3+ ion to Au0. The formation of gold nanoparticles has been established by FT-IR and UV-Vis spectroscopy, as well as by TEM, XRD, EDAX and AFM. The study suggests that M. jalapa flowers can be a cheap source as a reductant for the production of gold nanoparticles.


Subject(s)
Flowers/metabolism , Gold/chemistry , Metal Nanoparticles/chemistry , Metal Nanoparticles/ultrastructure , Microscopy, Atomic Force , Microscopy, Electron, Transmission , Mirabilis/metabolism , Oxidation-Reduction
SELECTION OF CITATIONS
SEARCH DETAIL